2. Academic Validation
  3. From bench to brain: novel thieno-oxazine hybrids as potent pleiotropic anti-Alzheimer's agents with in vivo/ in vitro validation and in silico insights

From bench to brain: novel thieno-oxazine hybrids as potent pleiotropic anti-Alzheimer's agents with in vivo/ in vitro validation and in silico insights

  • J Enzyme Inhib Med Chem. 2026 Dec;41(1):2598741. doi: 10.1080/14756366.2025.2598741.
Eman A Fayed 1,  Mazin A A Najm 2,  Khulood H Oudah 2,  Maha A Ebrahim 1,  Nirvana A Gohar 3,  Karema Abu-Elfotuh 4 5,  Ehsan Khedre Mohamed 6,  Ahmed M E Hamdan 7 8,  Najla A Albalawi 9,  Shahad Faisal Alzahrani 9,  Amira M Hamdan 10,  Reema Almotairi 8 11,  Shaimaa M Hafez 12,  Triveena M Ramsis 13
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.
  • 2 Department of Pharmacy, Mazaya University College, Nasiriyah, Iraq.
  • 3 Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Cairo, Egypt.
  • 4 Department of Clinical Pharmacy, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt.
  • 5 College of Pharmacy, Al-Ayen Iraqi University, Thi-Qar, Iraq.
  • 6 Department of Biochemistry, Egyptian Drug Authority (EDA), formerly National Organization of Drug Control and Research (NODCAR), Giza, Egypt.
  • 7 Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
  • 8 Prince Fahad Bin Sultan Chair for Biomedical Research (PFSCBR), University of Tabuk, Tabuk, Saudi Arabia.
  • 9 Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
  • 10 Oceanography Department, Faculty of Science, Alexandria University, Alexandria, Egypt.
  • 11 Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
  • 12 Department of Anatomy and Embryology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • 13 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sinai University, Ismailia, Egypt.
PMID: 41481412 DOI: 10.1080/14756366.2025.2598741
Abstract

Due to their various pharmacological effects, several substituted sulphur heterocycles containing thiophene have recently attracted a great deal of attention. A novel 2,3-diaryl-2,3,5,6,7,8-hexahydro-4H-benzo[4,5]thieno[3,2-e][1,3]oxazin-4-one (9-14) was synthesised starting from cyclohexa[b]thiophene. Compounds 9 and 10 showed the greatest gene expression downregulation of Bax by 75.1% and 79.7%, and upregulation of Bcl-2 gene expression by 8.1 folds for each. It also decreased the level of AChE by 70.2 and 75%; respectively. Compounds 9 and 10 significantly increased Wnt3a levels by 5.8 and 6.6 folds, and β-catenin levels by 10.1 and 10.5 folds, respectively, compared to donepezil. They significantly downregulated 5-GSK3β gene expression by 77.1%, and 78.7%, respectively. Even though all compounds exhibited potent inhibition of AChE, all synthesised compounds, except for compounds 5 and 11 demonstrated higher selectivity towards BChE (SI < 1). In-silico ADMET calculations as well as molecular docking have been performed for synthetic compounds.

Keywords

AChE and BChE inhibitors; ADMET and docking studies; Alzheimer’s disease; Thieno-oxazines; multi-targets and histopathological examinations.

Figures
Products